STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR): * Sales increased by 14 percent to SEK 47.5 (41.8) million during the fourth quarter. However, the underlying sales growth was 17 percent, corrected for negative currency effects. Net sales amounted to SEK 188.9 (171.3) million for the whole of 2007, an increase of 10 percent. Calculated in local sales currencies growth was 13 percent. * Sales growth of 20 percent in local cur
